BiotechTube
Home/GigaGen/Sheila Keating, Ph.D.
SK

Sheila Keating, Ph.D.

Vice President, Immunology

GigaGen

Therapeutic Areas

OncologyInfectious DiseasesImmunodeficienciesBiodefense

GigaGen Pipeline

DrugIndicationPhase
GIGA-564Advanced Solid TumorsPhase 1
GIGA-2339Chronic Hepatitis B Virus (HBV)Phase 1
Botulinum Neurotoxin ProgramBotulism (Biodefense)Pre-clinical/Development

Leadership Team at GigaGen

CK
Carter Keller
Chief Executive Officer
AA
Adam Adler, Ph.D.
Chief Scientific Officer
ES
Erica Stone, Ph.D.
Vice President, Oncology
RM
Rena Mizrahi, Ph.D.
Vice President, Process Development
JF
Jan Fredrik Simons
Senior Director, Technology
CM
Catherine Medina
Vice President, Operations
View full GigaGen profile